China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.258
+0.001 (0.51%)
Nov 4, 2024, 3:59 PM EST - Market closed
China Pharma Holdings Employees
China Pharma Holdings had 231 employees as of December 31, 2023. The number of employees decreased by 3 or -1.28% compared to the previous year.
Employees
231
Change (1Y)
-3
Growth (1Y)
-1.28%
Revenue / Employee
$27,047
Profits / Employee
-$19,064
Market Cap
4.42M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fresh2 Group | 75 |
| Oncternal Therapeutics | 30 |
| Theriva Biologics | 22 |
| Pasithea Therapeutics | 8 |
| Enveric Biosciences | 7 |
| Synaptogenix | 5 |
| Lixte Biotechnology Holdings | 4 |
| 180 Life Sciences | 4 |
CPHI News
- 2 months ago - China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 - PRNewsWire
- 9 months ago - China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split - PRNewsWire
- 1 year ago - China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device - PRNewsWire
- 1 year ago - China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs - PRNewsWire
- 1 year ago - China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 - PRNewsWire
- 2 years ago - China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project - PRNewsWire